Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrix-enabled gene transfer for cutaneous wound repair.

L A Chandler1, D L Gu, C Ma

  • 1Selective Genetics, Inc., 11035 Roselle Street, San Diego, CA 92121, USA.

Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|February 24, 2001
PubMed
Summary

Gene activated matrices improve chronic wound healing by delivering therapeutic genes directly to the wound site. This novel gene therapy approach enhances tissue repair more effectively than traditional protein therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physicochemical and functional characterization of the mucilage obtained from cladodes of two Opuntia species.

International journal of biological macromolecules·2024
Same author

Dualism, allosteric modulation, and biased signaling of opioid receptors: Future therapeutic potential.

Revista espanola de anestesiologia y reanimacion·2023
Same author

Homogeneous colleters in Myrteae (Myrtaceae).

Protoplasma·2023
Same author

Oromandibular-limb hypogenesis syndromes (OLHS): A challenge for airway management.

Revista espanola de anestesiologia y reanimacion·2021
Same author

Analysis of the care management protocol for COVID pregnant women and detection of improvement proposals applying clinical simulation methodology.

Revista espanola de anestesiologia y reanimacion·2020
Same author

Plant regeneration in Arachis pintoi (Leguminosae) through leaf culture.

Plant cell reports·2019

Area of Science:

  • Regenerative Medicine
  • Biotechnology
  • Dermatology

Background:

  • Traditional growth factor protein therapies for chronic wounds show limited efficacy due to poor delivery and retention.
  • Gene therapy offers a potential solution by enabling sustained therapeutic protein production within the wound.
  • Matrix-enabled gene transfer aims to improve both vector and protein retention at the wound site.

Purpose of the Study:

  • To evaluate matrix-enabled gene transfer (Gene Activated Matrix) for enhancing cutaneous wound repair.
  • To assess the efficacy of delivering therapeutic genes encoding platelet-derived growth factor (PDGF)-A or -B via collagen-based matrices.
  • To investigate the benefits of combining gene therapy with molecular targeting for improved wound healing.

Main Methods:

Related Experiment Videos

  • Formulations of bovine type I collagen combined with adenoviral or plasmid gene vectors encoding PDGF-A or -B were tested in three in vivo wound models.
  • Gene activated matrices were compared against controls including collagen alone and collagen with a reporter gene vector.
  • Molecular targeting was achieved by conjugating DNA vectors to basic fibroblast growth factor (bFGF).

    • Main Results:

    • Gene activated matrices significantly increased granulation tissue formation, vascularization, and reepithelialization compared to controls.
    • The combination of matrix-enabled gene transfer with molecular targeting further enhanced the tissue repair response.
    • Adenoviral and plasmid vectors demonstrated effectiveness in delivering therapeutic genes for wound healing.

    Conclusions:

    • Gene activated matrices show significant promise for treating chronic dermal wounds.
    • This approach overcomes limitations of protein therapy by ensuring sustained therapeutic protein availability and vector retention.
    • Further clinical evaluation of gene activated matrices for chronic wound management is warranted.